Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2010, Article ID 901564, 7 pages
http://dx.doi.org/10.1155/2010/901564
Research Article

Natural Killer Cell Cytotoxicity and Immunosuppressive Cytokines (IL-10, TGF- 1) in Patients with Gastric Cancer

1Department of Medical Microbiology, University of Medical Sciences in Poznań, Wieniawskiego 3 Street, 61-712 Poznań, Poland
2Department of General, Gastroenterological and Endocrinological Surgery, University of Medical Sciences in Poznań, Przybyszewskiego 49 Street, 60-355 Poznań, Poland
3Department of Clinical Pathomorphology, University of Medical Sciences in Poznań, Przybyszewskiego 49 Street, 60-355 Poznań, Poland

Received 18 August 2009; Accepted 16 February 2010

Academic Editor: Manoor Prakash Hande

Copyright © 2010 Andrzej Szkaradkiewicz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Colucci, M. A. Caligiuri, and J. P. Di Santo, “What does it take to make a natural killer?” Nature Reviews Immunology, vol. 3, no. 5, pp. 413–425, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. M. J. Soloski, “Recognition of tumor cells by the innate immune system,” Current Opinion in Immunology, vol. 13, no. 2, pp. 154–162, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Takeuchi, Y. Maehara, E. Tokunaga, T. Koga, Y. Kakeji, and K. Sugimachi, “Prognostic significance of natural killer cell activity in patients with gastric carcinoma: a multivariate analysis,” American Journal of Gastroenterology, vol. 96, no. 2, pp. 574–578, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. K. W. Moore, R. de Waal Malefyt, R. L. Coffman, and A. O'Garra, “Interleukin-10 and the interleukin-10 receptor,” Annual Review of Immunology, vol. 19, pp. 683–765, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. J.-L. Mege, S. Meghari, A. Honstettre, C. Capo, and D. Raoult, “The two faces of interleukin 10 in human infectious diseases,” The Lancet Infectious Diseases, vol. 6, no. 9, pp. 557–569, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. J. J. Letterio and A. B. Roberts, “Regulation of immune responses by TGF-β,” Annual Review of Immunology, vol. 16, pp. 137–161, 1998. View at Publisher · View at Google Scholar · View at Scopus
  7. D. M. Kingsley, “The TGF-β superfamily: new members, new receptors, and new genetic tests of function in different organisms,” Genes and Development, vol. 8, no. 2, pp. 133–146, 1994. View at Google Scholar · View at Scopus
  8. F. De Vita, M. Orditura, G. Galizia et al., “Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies,” Cancer, vol. 86, no. 10, pp. 1936–1943, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Nakamura, M. Katano, A. Kuwahara et al., “Transforming growth factor ß1 (TGF-ß1) is a preoperative prognostic indicator in advanced gastric carcinoma,” British Journal of Cancer, vol. 78, no. 10, pp. 1373–1378, 1998. View at Google Scholar
  10. IARC Working Group, “Schistosomes, liver flukes and Helicobacter pylori: views and expert opinion of IARC working group on the evaluation of carcinogenic risks to humans,” International Agency for Research on Cancer, vol. 61, pp. 177–240, 1994. View at Google Scholar
  11. T. Matysiak-Budnik and F. Mégraud, “Helicobacter pylori infection and gastric cancer,” European Journal of Cancer, vol. 42, no. 6, pp. 708–716, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Hafsi, P. Voland, S. Schwendy et al., “Human dendritic cells respond to Helicobacter pylori, promoting NK cell and Th1-effector responses in vitro,” Journal of Immunology, vol. 173, no. 2, pp. 1249–1257, 2004. View at Google Scholar · View at Scopus
  13. S. R. Hamilton and A. Aaltonen, Pathology and Genetics of Tumours of the Digestive System: Tumours of the Stomach, IARC Press, Lyon, France, 2000.
  14. Y. Yamaguchi, I. Takashima, M. Funakoshi, H. Kawami, and T. Toge, “Defective natural killer activity in gastric cancer patients: possible involvement of suppressor factor receptor,” In Vivo, vol. 8, no. 3, pp. 279–284, 1994. View at Google Scholar · View at Scopus
  15. C. Fortis, M. Foppoli, L. Gianotti et al., “Increased interleukin-10 serum levels in patients with solid tumours,” Cancer Letters, vol. 104, no. 1, pp. 1–5, 1996. View at Publisher · View at Google Scholar · View at Scopus
  16. G. Cai, R. A. Kastelein, and C. A. Hunter, “IL-10 enhances NK cell proliferation, cytotoxicity and production of IFN-γ when combined with IL-18,” European Journal of Immunology, vol. 29, no. 9, pp. 2658–2665, 1999. View at Google Scholar · View at Scopus
  17. S. Mocellin, M. Panelli, E. Wang et al., “IL-10 stimulatory effects on human NK cells explored by gene profile analysis,” Genes and Immunity, vol. 5, no. 8, pp. 621–630, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Taylor, J. Verhagen, K. Blaser, M. Akdis, and C. A. Akdis, “Mechanisms of immune suppression by interleukin-10 and transforming growth factor-β: the role of T regulatory cells,” Immunology, vol. 117, no. 4, pp. 433–442, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. Q. S. Wen, G. Z. Zhang, and X. T. Kong, “Modulation effect of cimetidine on the production of IL-2 and interferon-γ in patients with gastric cancer,” Chinese Journal of Oncology, vol. 16, no. 4, pp. 299–301, 1994. View at Google Scholar
  20. C. A. J. Vosshenrich, S. I. Samson-Villéger, and J. P. Di Santo, “Distinguishing features of developing natural killer cells,” Current Opinion in Immunology, vol. 17, no. 2, pp. 151–158, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. S. H. Chan, B. Perussia, J. W. Gupta et al., “Induction of interferon ? production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers,” Journal of Experimental Medicine, vol. 173, no. 4, pp. 869–879, 1991. View at Google Scholar · View at Scopus
  22. D. Thong-Ngam, P. Tangkijvanich, R. Lerknimitr, V. Mahachai, A. Theamboonlers, and Y. Poovorawan, “Diagnostic role of serum interleukin-18 in gastric cancer patients,” World Journal of Gastroenterology, vol. 12, no. 28, pp. 4473–4477, 2006. View at Google Scholar · View at Scopus
  23. P. C. Konturek, J. Kania, J. W. Konturek, A. Nikiforuk, S. J. Konturek, and E. G. Hahn, “H. pylori infection, atrophic gastritis, cytokines, gastrin, COX-2, PPARγ and impaired apoptosis in gastric carcinogenesis,” Medical Science Monitor, vol. 9, no. 7, pp. SR53–SR66, 2003. View at Google Scholar · View at Scopus
  24. C.-F. Zambon, D. Basso, F. Navaglia et al., “Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome,” Cytokine, vol. 29, no. 4, pp. 141–152, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. E.M. El-Omar, C. S. Rabkin, M. D. Gammon et al., “Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms,” Gastroenterology, vol. 124, no. 5, pp. 1193–1201, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. C. H. Yun, A. Lundgren, J. Azem et al., “Natural killer cells and Helicobacter pylori infection: bacterial antigens and interleukin-12 act synergistically to induce gamma interferon production,” Infection and Immunity, vol. 73, no. 3, pp. 1482–1490, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. M. A. Cooper, T. A. Fehniger, and M. A. Caligiuri, “The biology of human natural killer-cell subsets,” Trends in Immunology, vol. 22, no. 11, pp. 633–640, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Jacobs, G. Hintzen, A. Kemper et al., “CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells,” European Journal of Immunology, vol. 31, no. 10, pp. 3121–3126, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. Z. Ren, G. Pang, R. Clancy et al., “Gastric carcinoma: T-cell response and vascularity. Shift of the gastric T-cell response in gastric carcinoma,” Journal of Gastroenterology and Hepatology, vol. 16, no. 2, pp. 142–148, 2001. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Vagenas, C. Spyropoulos, V. Gavala, and A. C. Tsamandas, “TGFβ1, TGFβ2, and TGFβ3 protein expression in gastric carcinomas: correlation with prognostics factors and patient survival,” Journal of Surgical Research, vol. 139, no. 2, pp. 182–188, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. P.-E. Gleizes, J. S. Munger, I. Nunes et al., “TGF-ß latency: biological significance and mechanisms of activation,” Stem Cells, vol. 15, no. 3, pp. 190–197, 1997. View at Google Scholar · View at Scopus
  32. L. M. Wakefield, J. J. Letterio, T. Chen et al., “Transforming growth factor-ß1 circulates in normal human plasma and is unchanged in advanced metastatic breast cancer,” Clinical Cancer Research, vol. 1, no. 1, pp. 129–136, 1995. View at Google Scholar